ARCHIVES

Conference On Delayed Consequences Of Cancer Therapy Scheduled Jan. 9-11

This article is from The Cancer Letter archive.

Vol. 01 No. 01 | January 3, 1975

Download PDF Visit The Full Archive

Related Articles

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

In Brief: Basic Research Chief At Frederick Will Be A Nominal Litton Employee To Avoid NCI Staff, Salary Ceilings

March 1, 1974

DeVita Says He Did Not Agree To Include “Chop-Like” Elements In CCOP RFA But That He Would Consider It

March 19, 1982

New Cancer Education Grant Program Guidelines, Developed

February 6, 1987

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

July 25, 2014

ASCO: NCI Authorities Still Important

June 11, 2010